<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for BRLI</title>
    <link />
    <description>Headlines for Bio-Reference Laboratories, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>How Dangerous are Five of the Most Heavily Shorted Small Cap Stocks?</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3536118/how-dangerous-are-five-of-the-most-heavily-shorted-small-cap-stocks.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 17 May 2013 16:15:00 GMT</pubDate>
    </item>
    <item>
      <title>BRLI Crosses Above Key Moving Average Level</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11920585/1/brli-crosses-above-key-moving-average-level.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 10 May 2013 16:24:00 GMT</pubDate>
    </item>
    <item>
      <title>Super-Fast Growing Mid-Cap Growth Stocks With Explosive Returns</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1424321-super-fast-growing-mid-cap-growth-stocks-with-explosive-returns.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 13:02:42 GMT</pubDate>
    </item>
    <item>
      <title>The Nasdaq's 5 Most Hated Stocks</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/03/the-nasdaqs-5-most-hated-stocks-2/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 03 May 2013 17:45:00 GMT</pubDate>
    </item>
    <item>
      <title>10 Piotroski Stocks To Beat The Market</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1354171-10-piotroski-stocks-to-beat-the-market.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 19 Apr 2013 10:13:30 GMT</pubDate>
    </item>
    <item>
      <title>Why Bio-Reference Laboratories Is A Dangerous Investment</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1336561-why-bio-reference-laboratories-is-a-dangerous-investment.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 11 Apr 2013 19:32:50 GMT</pubDate>
    </item>
    <item>
      <title>Why Bio-Reference Laboratories Is Dangerous Investment</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1336561-why-bio-reference-laboratories-is-dangerous-investment.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 11 Apr 2013 19:32:50 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Reference: Claims Don't Match The Evidence</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1244821-bio-reference-claims-don-t-match-the-evidence.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 04 Mar 2013 14:22:49 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Benchmark Company Raises PT on Bio-Reference Laboratories on Organic Earnings Growth Trend</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3381919/update-benchmark-company-raises-pt-on-bio-reference-labo.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 01 Mar 2013 12:24:25 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Reference Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1235151-bio-reference-laboratories-management-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 28 Feb 2013 15:50:21 GMT</pubDate>
    </item>
    <item>
      <title>5 Hated Stocks Poised to Pop on Earnings</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-hated-stocks-poised-pop-earnings.html-2.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 26 Feb 2013 12:50:00 GMT</pubDate>
    </item>
    <item>
      <title>A Portfolio For The Next Market Crash</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1187781-a-portfolio-for-the-next-market-crash.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 15 Feb 2013 10:51:40 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Reference Laboratories Inc. Enters Oversold Territory - Tale of the Tape</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/92205/bio-reference-laboratories-inc-enters-oversold-territory.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 07 Feb 2013 10:43:01 GMT</pubDate>
    </item>
    <item>
      <title>Top 4 Small-Cap Stocks In The Medical Laboratories &amp; Research Industry With The Highest Revenue Esti</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/13/02/3307559/top-4-small-cap-stocks-in-the-medical-laboratories-research-industry-wit.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 06 Feb 2013 03:08:59 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Proper Is Overbought, Time To Look At Alternatives</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1153571-biotech-proper-is-overbought-time-to-look-at-alternatives.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 04 Feb 2013 04:23:03 GMT</pubDate>
    </item>
    <item>
      <title>4 Stocks Rising on Unusual Volume</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-stocks-rising-unusual-volume.html-7.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 22 Jan 2013 15:06:00 GMT</pubDate>
    </item>
    <item>
      <title>4 Investing Lessons From Questcor's 2012</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/19/4-investing-lessons-from-questcors/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 19 Dec 2012 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>9 High-Growth Healthcare Stocks With Bearish Stock Trends</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1073241-9-high-growth-healthcare-stocks-with-bearish-stock-trends.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 19 Dec 2012 12:31:03 GMT</pubDate>
    </item>
    <item>
      <title>Buffett-Munger Model Portfolio Posts Fourth Solid Year, Hits Refresh for 2013</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/201692/buffettmunger-model-portfolio-posts-fourth-solid-year-hits-refresh-for-2013.aspx</link>
      <author>GuruFocus</author>
      <pubDate>Fri, 14 Dec 2012 18:10:20 GMT</pubDate>
    </item>
    <item>
      <title>A Case of Vertigo From Vertex Pharmaceuticals?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/14/a-case-of-vertigo-from-vertex-pharmaceuticals/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 14 Dec 2012 09:56:00 GMT</pubDate>
    </item>
  </channel>
</rss>
